Sandoz Pledges Price Stability Amid Coronavirus

CEO Richard Saynor Discusses Chinese Supply-Chain Pressures

Sandoz CEO Richard Saynor has pledged that the company will ensure stable pricing for essential coronavirus-related medicines amid concerns over how the outbreak will affect the supply chain.

Covid-19
Sandoz will ensure stable pricing for a basket of coronavirus-related essential drugs • Source: Shutterstock

Sandoz will maintain stable pricing for coronavirus-related essential medicines that it markets, CEO Richard Saynor has pledged, amid ongoing concerns over the potential short-term and longer-term impacts of the outbreak on the supply chain.

As “the number one provider of off-patent antibiotic medicines worldwide,” Sandoz said it was “making a public commitment to ensure...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Drug Pricing

More from Policy & Regulation

  • For Generics, A Victory Lap – And A Warning – On Drug Shortages

    Avoiding disaster at the beginning of the pandemic and offering a pro-active supply chain blueprint should position the generics industry well for an onshoring debate in Congress, but a look back at March 2020 is a reminder that even small policy shifts can have a big impact.

  • GB-Policy&Regulation-Free: Article with different widgets

    Emerging CRISPR innovations, shifting regulatory landscapes, and rising partnerships are accelerating a paradigm shift in biotech pipelines

  • Overseas API Manufacturing Identified As Key Vulnerability In US Supply Chain

    After US President Joe Biden launched a review of the country’s API supply chain, the task force has reported back with key vulnerabilities that contribute to drug shortages and supply risks during a global public health emergency. According to the report, the lack of geographic diversity and dependence on foreign nations and anti-competitive actions by foreign nations are key areas of concern.